Observational studyFrontiers in endocrinology2022

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).

Cesare C Berra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.